• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Elekta

51.25 SEK

+0.99 %

Less than 1K followers

EKTA B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.99 %
-2.66 %
-5.88 %
-9.69 %
-9.69 %
+4.42 %
-38.50 %
-58.74 %
+487.49 %

Elekta operates in the medical technology industry and focuses on the development, manufacture and distribution of medical equipment for cancer treatment and neurosurgery. The company's products include radiotherapy machines and diagnostic imaging systems. The business has a global market position. Elekta was founded in 1972 and is headquartered in Stockholm.

Read more
Market cap
19.66B SEK
Turnover
25.82M SEK
Revenue
16.72B
EBIT %
1.4 %
P/E
-
Dividend yield-%
4.68 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27.8
2026

Interim report Q1'27

3.9
2026

General meeting '26

4.9
2026

Half year dividend

Regulatory press release17.06.2026, 09.30

Elekta presents financial targets and detailed outlook ahead of Capital Markets Day

Elekta
Press release12.06.2026, 07.30

Nomination Committee’s proposal for the Board of Directors prior to Elekta’s Annual General Meeting 2026

Elekta
Regulatory press release28.05.2026, 07.30

Year-end report May–April 2025/26

Elekta

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release18.05.2026, 07.30

New research presented at ESTRO 2026 highlights advances in MR-guided radiotherapy

Elekta
Press release13.05.2026, 07.30

Invitation to the presentation of Elekta’s fiscal year 2025/26

Elekta
Press release17.04.2026, 07.00

Invitation to Elekta's Capital Markets Day on June 17, 2026

Elekta
Regulatory press release05.03.2026, 07.30

Third quarter, November–January 2025/26

Elekta
Regulatory press release25.02.2026, 07.30

Change in Elekta’s Nomination Committee for the Annual General Meeting 2026

Elekta
Press release19.02.2026, 07.30

Invitation to Elekta’s Q3 2025/26 call at 9:00 a.m. CET, March 5

Elekta
Press release30.01.2026, 12.00

Elekta presents Strategic Update: growth, innovation, and operations

Elekta
Press release23.01.2026, 11.10

Elekta appoints Tomas Eliasson as Vice Chair of the Board

Elekta
Regulatory press release16.01.2026, 09.54

Elekta receives FDA 510(k) clearance for Elekta Evo linear accelerator

Elekta
Press release12.01.2026, 10.00

Invitation to Elekta's Strategic Update event on January 30

Elekta
Regulatory press release26.11.2025, 07.30

Second quarter, August–October 2025/26

Elekta
Press release12.11.2025, 07.30

Invitation to the presentation of Elekta’s second quarter 2025/26

Elekta
Regulatory press release31.10.2025, 07.30

Elekta’s Nomination Committee for the Annual General Meeting 2026

Elekta
Press release09.10.2025, 07.30

New impact report reveals radiotherapy’s role in cancer care

Elekta
Press release29.09.2025, 20.10

Study shows MRI-guided adaptive radiotherapy with Elekta Unity improves patient-reported urinary symptoms in men with prostate cancer

Elekta
Press release25.09.2025, 07.30

Elekta marks two millionth patient treated with Leksell Gamma Knife radiosurgery

Elekta
Regulatory press release08.09.2025, 07.30

Elekta announces changes in Executive Management

Elekta